Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Abstract
First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins to protect against genome instability and reduce the risk of cancer and other pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 (TP53), which is a major target of the PI3K-related protein kinases (PI3K) ATM and ATR and that plays a pivotal role in DDR 5”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [5]
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [48]
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“Indeed, chloroquine and other agents that alter chromatin structure can cause partial activation of ATM in the absence of DNA DSB”
BackgroundATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 1×
“ATM has multiple substrates — indeed, recent proteomic analysis of phosphoproteins induced by DNA damage suggest that the ATM and ATR network might have as many as 700 substrate”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“This was not surprising, because the stabilization and activation of p53 was defective in A-T cells, and these cells were also characterized by a defective G1–S checkpoint, in which p53 has a central rol”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · cited 1×
“DNA breaks per se can also be beneficial in that they activate a DNA-damage response in pre-cancerous cells, thereby establishing a barrier to tumour progressio”
BackgroundATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Research works printed but not linked: 2
- Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541–562 (1926) (in French).
- Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649–656 (1999). · doi:10.1002/(sici)1521-1878(199908)21:8<649::aid-bies4>3.0.co;2-o
Cited by
Items 201–300 of 898
The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate
Eliaš, J., Dimitrio, L., Clairambault, J., & Natalini, R. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.09.019 · Cited by 81
Genome maintenance and transcription integrity in aging and disease
Wolters, S., & Schumacher, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00019 · Cited by 71
“Heritable mutations in ATM result in ataxia telangiectasia (AT), a rare recessive syndrome that is associated with progressive neurodegeneration, variable kinds of immunedeficiencies and a predisposition to lymphoid cancer (Lavin, 2008).”
Lim, Y. C., Roberts, T. L., Day, B. W., Stringer, B. W., Kozlov, S., Fazry, S., Bruce, Z. C., Ensbey, K. S., Walker, D., Boyd, A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.012 · Cited by 80
“In the presence of DNA damage, the Mre11/Rad50/Nbs1 (MRN) complex recruits and activates ATM and other DNA damage response proteins to the DNA termini (Lavin, 2008).”
BackgroundSelf-citationFunctional overlaps between XLF and the ATM-dependent DNA double strand break response
Kumar, V., Alt, F. W., & Oksenych, V. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.01.010 · Cited by 79
Yurov, Y. B., Vorsanova, S. G., & Iourov, I. Y. (2009) · Molecular Cytogenetics · doi:10.1186/1755-8166-2-23 · Cited by 73
“Clinical and molecular studies of this disease have brought tremendous advances in molecular and cell biology of cell cycle, cancerization, immunodeficiency and aging as well as neurobiology of human disease [20,50].”
Role of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 77
AMPK regulates metabolism and survival in response to ionizing radiation
Zannella, V. E., Cojocari, D., Hilgendorf, S., Vellanki, R. N., Chung, S., Wouters, B. G., & Koritzinsky, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.049 · Cited by 71
Kwon, S.-J., Park, J.-H., Park, E.-J., Lee, S.-A., Lee, H.-S., Kang, S. W., & Kwon, J. (2014) · Oncogene · doi:10.1038/onc.2013.556 · Cited by 73
Rübe, C. E., Fricke, A., Schneider, R., Simon, K., Kühne, M., Fleckenstein, J., Graeber, S. M., Graf, N. M., & Rübe, C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.052 · Cited by 71
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53
Sullivan, K. D., Padilla-Just, N., Henry, R. E., Porter, C. C., Kim, J., Tentler, J. J., Eckhardt, S. G., Tan, A. C., DeGregori, J., & Espinosa, J. M. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.965 · Cited by 67
“Current dogma maintains that ATM activates p53 in response to DNA damage by phosphorylating specific serines in both p53 and MDM2, thus preventing their interaction and leading to p53 stabilization 44 .”
Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation
Filipponi, D., Müller, J., Emelyanov, A., & Bulavin, D. V. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.022 · Cited by 71
Karlin, J. D., Allen, J., Ahmad, S. F., Hughes, G. D., Sheridan, V. H., Odedra, R., Farrington, P. M., Cadogan, E. B., Riches, L. C., Garcia-Trinidad, A., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0975 · Cited by 72
Mladenov, E., Fan, X., Dueva, R., Soni, A., & Iliakis, G. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-44771-6 · Cited by 74
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
Palmieri, D., Valentino, T., D’Angelo, D., Martino, I. D., Postiglione, I., Pacelli, R., Croce, C. M., Fedele, M., & Fusco, A. (2011) · Oncogene · doi:10.1038/onc.2011.21 · Cited by 73
Somyajit, K., Basavaraju, S., Scully, R., & Nagaraju, G. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01521-12 · Cited by 77
Induced Pluripotent Stem Cells from Ataxia-Telangiectasia Recapitulate the Cellular Phenotype
Nayler, S., Gatei, M. H., Kozlov, S., Gatti, R. A., Mar, J. C., Wells, C. A., Lavin, M. F., & Wolvetang, E. J. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0024 · Cited by 70
Self-citationLevy‐Barda, A., Lerenthal, Y., Davis, A. J., Chung, Y. M., Essers, J., Shao, Z., van Vliet, N., Chen, D. J., Hu, M. C. ‐., Kanaar, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18642 · Cited by 73
ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas
Bueno, R. C., Canevari, R. D. A., Villacis, R. A. R., Domingues, M. A. C., Caldeira, J. R. F., Rocha, R. M., Drigo, S. A., & Rogatto, S. R. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt421 · Cited by 65
ATM-dependent pathways of chromatin remodelling and oxidative DNA damage responses
Berger, N. D., Stanley, F. K. T., Moore, S., & Goodarzi, A. A. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0283 · Cited by 68
Skaro, M. F., Nanda, N., Gauthier, C. D., Felsenstein, M., Jiang, Z., Qiu, M., Shindo, K., Yu, J., Hutchings, D., Javed, A. A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.254 · Cited by 70
Menotta, M., Biagiotti, S., Bianchi, M., Chessa, L., & Magnani, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344473 · Cited by 64
From the Rarest to the Most Common: Insights from Progeroid Syndromes into Skin Cancer and Aging
Capell, B. C., Tlougan, B. E., & Orlow, S. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.103 · Cited by 69
N-myc and Noncoding RNAs in Neuroblastoma
Buechner, J., & Einvik, C. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0244 · Cited by 76
Estrogen Receptor α Regulates ATM Expression through miRNAs in Breast Cancer
Guo, X., Yang, C., Qian, X., Lei, T., Li, Y., Shen, H., Fu, L., & Xu, B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3700 · Cited by 65
Nitta, E., Yamashita, M., Hosokawa, K., Xian, M., Takubo, K., Arai, F., Nakada, S., & Suda, T. (2011) · Blood · doi:10.1182/blood-2010-08-297390 · Cited by 64
ATM kinase sustains HER2 tumorigenicity in breast cancer
Stagni, V., Manni, I., Oropallo, V., Mottolese, M., Di Benedetto, A., Piaggio, G., Falcioni, R., Giaccari, D., Di Carlo, S., Sperati, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms7886 · Cited by 64
DNA damage response in microcephaly development of MCPH1 mouse model
Zhou, Z., Tapias, A., Bruhn, C., Gruber, R., Sukchev, M., & Wang, Z. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.017 · Cited by 65
Radiation-induced bystander effect: Early process and rapid assessment
Wang, H., Yu, K. N., Hou, J., Liu, Q., & Han, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.031 · Cited by 67
The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis
Hao, Z., Duncan, G. S., Su, Y.-W., Li, W. Y., Silvester, J., Hong, C., You, H., Brenner, D., Gorrini, C., Haight, J., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111363 · Cited by 69
High-resolution melting curve analysis for rapid detection of mutations in a Medaka TILLING library
Ishikawa, T., Kamei, Y., Otozai, S., Kim, J., Sato, A., Kuwahara, Y., Tanaka, M., Deguchi, T., Inohara, H., Tsujimura, T., et al. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-70 · Cited by 66
Gray, P. N., Dunlop, C. L. M., & Elliott, A. M. (2015) · Cancers · doi:10.3390/cancers7030837 · Cited by 68
Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly
Matsumoto, Y., Miyamoto, T., Sakamoto, H., Izumi, H., Nakazawa, Y., Ogi, T., Tahara, H., Oku, S., Hiramoto, A., Shiiki, T., et al. (2011) · DNA repair · doi:10.1016/j.dnarep.2010.12.002 · Cited by 74
Yeo, A. J., Bécherel, O. J., Luff, J., Cullen, J. K., Wongsurawat, T., Jenjaroenpoon, P., Kuznetsov, V. A., McKinnon, P. J., & Lavin, M. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090219 · Cited by 72
Self-citationWójcicka, A., Czetwertyńska, M., Świerniak, M., Długosińska, J., Maciąg, M., Czajka, A., Dymecka, K., Kubiak, A., Kot, A., Płoski, R., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22162 · Cited by 67
“Variants in ATM are associated with a number of cancer types (Lavin, 2008).”
Lavin, M. F. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.014 · Cited by 62
Self-citationCowan, M. J., & Gennery, A. R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.027 · Cited by 61
Kim, T. I. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1448 · Cited by 63
Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion
Marque, M., Roubertie, A., Jaussent, A., Carneiro, M., Meunier, L., Guillot, B., Pinson, L., Pinson, S., & Bessis, D. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.039 · Cited by 59
Keimling, M., Volčič, M., Csernok, A., Wieland, B., Dörk, T., & Wiesmüller, L. (2011) · The FASEB Journal · doi:10.1096/fj.11-185546 · Cited by 65
Westbrook, A. M., & Schiestl, R. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2584 · Cited by 59
Wong, S. Q., Li, J., Salemi, R., Sheppard, K. E., Do, H., Tothill, R. W., McArthur, G. A., & Dobrovic, A. (2013) · Scientific Reports · doi:10.1038/srep03494 · Cited by 65
Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity
Rainville, I. R., & Rana, H. Q. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0371-z · Cited by 66
Segal, H., Mass, G., Baranes‐Bachar, K., Lerenthal, Y., Wang, S., Chung, Y. M., Ziv‐Lehrman, S., Ström, C. E., Helleday, T., Hu, M. C. ‐., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.96 · Cited by 63
STK38 promotes ATM activation by acting as a reader of histone H4 ufmylation
Qin, B., Yu, J., Nowsheen, S., Zhao, F., Wang, L., & Lou, Z. (2020) · Science Advances · doi:10.1126/sciadv.aax8214 · Cited by 61
Dai, C.-H., Chen, P., Li, J., Lan, T., Chen, Y., Qian, H., Chen, K., & Li, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11214 · Cited by 62
Emerging Connection Between Centrosome and DNA Repair Machinery
Shimada, M., & Komatsu, K. (2009) · Journal of Radiation Research · doi:10.1269/jrr.09039 · Cited by 56
Bazzichetto, C., Luchini, C., Conciatori, F., Vaccaro, V., Cello, I. D., Mattiolo, P., Falcone, I., Ferretti, G., Scarpa, A., Cognetti, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228841 · Cited by 59
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 71
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover
Bohgaki, M., Hakem, A., Halaby, M. J., Bohgaki, T., Li, Q., Bissey, P.-A., Shloush, J., Kislinger, T., Sanchez, O., Sheng, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.7 · Cited by 56
Geuting, V., Reul, C., & Löbrich, M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003667 · Cited by 58
Tdp1 protects against oxidative DNA damage in non‐dividing fission yeast
Hassine, S. B., & Arcangioli, B. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.9 · Cited by 58
WEE1 tyrosine kinase, a novel epigenetic modifier
Mahajan, K. N., & Mahajan, N. P. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.02.003 · Cited by 61
Biological consequences of formation and repair of complex DNA damage
Magnander, K., & Elmroth, K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.013 · Cited by 61
Alao, J. P., & Sunnerhagen, P. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-51 · Cited by 64
Gerlitz, G. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.10.007 · Cited by 63
Chen, Y., Wei, M., Wang, C.-W., Lee, H.-W., Pan, S., Gao, M., Kuo, S., Cheng, A., & Teng, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.015 · Cited by 55
Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response
Lee, H.-J., Lan, L., Peng, G., Chang, W., Hsu, M., Wang, Y., Cheng, C. C., Wei, L., Nakajima, S., Chang, S.-S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.8 · Cited by 59
Self-citationYamamoto, K., Wang, J., Sprinzen, L., Xu, J., Haddock, C. J., Li, C., Lee, B. J., Loredan, D. G., Jiang, W., Vindigni, A., et al. (2016) · eLife · doi:10.7554/elife.14709 · Cited by 58
Cros, J. F., Théou–Anton, N., Gounant, V., Nicolle, R., Réyès, C., Humez, S., Hescot, S., de Montpréville, V., Guyétant, S., Scoazec, J., et al. (2020) · Neuroendocrinology · doi:10.1159/000506292 · Cited by 52
DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders
Provasek, V. E., Mitra, J., Malojirao, V. H., & Hegde, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094653 · Cited by 55
Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia
Kraus, M., Lev, A., Simon, A. J., Levran, I., Nissenkorn, A., Levi, Y. B., Berkun, Y., Efrati, O., Amariglio, N., Rechavi, G., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0044-1 · Cited by 51
Emerging role of tumor suppressor p53 in acute and chronic kidney diseases
Overstreet, J. M., Gifford, C. C., Tang, J., Higgins, P. J., & Samarakoon, R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04505-w · Cited by 58
ATM–Dependent MiR-335 Targets CtIP and Modulates the DNA Damage Response
Martin, N. T., Nakamura, K., Davies, R. C., Nahas, S., Brown, C., Tunuguntla, R., Gatti, R. A., & Hu, H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003505 · Cited by 54
Jacquemin, V., Rieunier, G., Jacob, S., Bellanger, D., d’Enghien, C. D., Laugé, A., Stoppa‐Lyonnet, D., & Stern, M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.196 · Cited by 63
Clinical potential of ATM inhibitors
Lavin, M. F., & Yeo, A. J. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111695 · Cited by 56
Self-citationGrowth retardation and growth hormone deficiency in patients with Ataxia telangiectasia
Voss, S., Pietzner, J., Hoche, F., Taylor, A. M. R., Last, J. I. K., Schubert, R., & Zielen, S. (2014) · Growth Factors · doi:10.3109/08977194.2014.939805 · Cited by 51
Sanli, T., Storozhuk, Y., Linher‐Melville, K., Bristow, R. G., Laderoute, K. R., Viollet, B., Wright, J. R., Singh, G., & Tsakiridis, T. K. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.11.014 · Cited by 50
Hong, S.-T., & Choi, K. (2013) · Nature Communications · doi:10.1038/ncomms3986 · Cited by 49
Köcher, S., Rieckmann, T., Rohaly, G., Mansour, W. Y., Dikomey, E., Dornreiter, I., & Dahm‐Daphi, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks604 · Cited by 56
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
Landais, I., Hiddingh, S., McCarroll, M. N., Yang, C., Sun, A., Turker, M. S., Snyder, J. P., & Hoatlin, M. E. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-133 · Cited by 55
Mukherjee, B., Choy, H., Nirodi, C. S., & Burma, S. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.002 · Cited by 53
Inflammation, a significant player of Ataxia–Telangiectasia pathogenesis?
Zaki‐Dizaji, M., Akrami, S. M., Azizi, G., Abolhassani, H., & Aghamohammadi, A. (2018) · Inflammation Research · doi:10.1007/s00011-018-1142-y · Cited by 50
Wilson, P. F., Nham, P. B., Urbin, S. S., Hinz, J. M., Jones, I. M., & Thompson, L. H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.10.013 · Cited by 48
Kumar, R., Hunt, C. R., Gupta, A. K. D., Nannepaga, S., PANDITA, R. K., Shay, J. W., Bachoo, R. M., Ludwig, T., Burns, D. K., & Pandita, T. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016524108 · Cited by 46
Kinoshita, T., Nagamatsu, G., Kosaka, T., Takubo, K., Hotta, A., Ellis, J., & Suda, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.013 · Cited by 48
Izumi, N., Yamashita, A., Hirano, H., & Ohno, S. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02112.x · Cited by 51
Redox regulation of SUMO enzymes is required for ATM activity and survival in oxidative stress
Stankovic‐Valentin, N., Drzewicka, K., König, C., Schiebel, E., & Melchior, F. (2016) · The EMBO Journal · doi:10.15252/embj.201593404 · Cited by 50
Quek, H., Luff, J., Cheung, K., Kozlov, S., Gatei, M., Lee, C. S., Bellingham, M. C., Noakes, P. G., Lim, Y. C., Barnett, N. L., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4vma0716-316r · Cited by 46
Self-citationAbdominal actinomycosis: evaluation by computed tomography.
Harris, L. A., DeCosse, J. J., & Dannenberg, A. J. (1989) · PubMed · Cited by 47
Lee, J. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102808 · Cited by 57
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
Shahjahani, M., Asl, J. M., Norozi, F., Seghatoleslami, M., Shahrabi, S., Saba, F., & Saki, N. (2015) · Cellular Oncology · doi:10.1007/s13402-014-0215-3 · Cited by 59
Structural insights into the activation of ATM kinase
Xiao, J., Liu, M., Qi, Y., Chaban, Y. L., Gao, C., Pan, B.-Q., Tian, Y., Yu, Z., Li, J., Zhang, P., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0205-0 · Cited by 48
Inherited Cancer Syndromes in Children and Young Adults
D'Orazio, J. A. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181ced34c · Cited by 48
Duan, X., Ponomareva, L. V., Veeranki, S., & Choubey, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019532 · Cited by 55
Morris, A. C., Forbes-Osborne, M. A., Pillai‐Kastoori, L., & Fadool, J. M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6022 · Cited by 45
Accumulation of DNA Double-Strand Breaks in Normal Tissues After Fractionated Irradiation
Rübe, C. E., Fricke, A., Wendorf, J., Stützel, A. B., Kühne, M., Ong, M. F., Lipp, P., & Rübe, C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.009 · Cited by 49
Integrated regulation of PIKK-mediated stress responses by AAA+ proteins RUVBL1 and RUVBL2
Izumi, N., Yamashita, A., & Ohno, S. (2012) · Nucleus · doi:10.4161/nucl.18926 · Cited by 50
Erttmann, S. F., Härtlová, A., Słoniecka, M., Raffi, F. A. M., Hosseinzadeh, A., Edgren, T., Rofougaran, R., Resch, U., Fällman, M., Ek, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.018 · Cited by 47
Mak, J. P. Y., Ma, H. T., & Poon, R. Y. C. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0474 · Cited by 46
The Impact of Oxidative Stress on Pediatrics Syndromes
Micangeli, G., Menghi, M., Profeta, G., Tarani, F., Mariani, A., Petrella, C., Barbato, C., Ferraguti, G., Ceccanti, M., Tarani, L., et al. (2022) · Antioxidants · doi:10.3390/antiox11101983 · Cited by 63
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia
Byrd, P. J., Srinivasan, V., Last, J. I., Smith, A. J. B., Biggs, P., Carney, E. F., Exley, A., Abson, C., Stewart, G. S., Izatt, L., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.534 · Cited by 44
“ATM phosphorylates many target proteins such as H2AX, MDC1, 53BP1, Nbs1, BRCA1, Chk2 and p53 that function to regulate DNA DSB repair, chromatin remodelling, cell cycle checkpoint activation, gene transcription, protein translation and apoptosis (Lavin, 2008).”
Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway
Guo, Q., Wang, S.-S., Jiang, X.-Y., Xie, X.-C., Zou, Y. F., Liu, J., Guo, Y., Li, Y., Xm, L., Hao, S., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502841122 · Cited by 59
“The protein kinase ATM is known to be a master regulator of double - strand DNA break (DSB) signaling and stress responses ( 4 , 5 ).”
Ataxia Telangiectasia Mutated Kinase Controls Chronic Gammaherpesvirus Infection
Kulinski, J. M., Leonardo, S. M., Mounce, B. C., Malherbe, L. P., Gauld, S. B., & Tarakanova, V. L. (2012) · Journal of Virology · doi:10.1128/jvi.00917-12 · Cited by 43
Apelin Is Required for Non-Neovascular Remodeling in the Retina
McKenzie, J. A. G., Fruttiger, M., Abraham, S., Lange, C., Stone, J., Gandhi, P., Wang, X., Bainbridge, J. W., Moss, S. E., & Greenwood, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.035 · Cited by 42
Zhang, Y., Xie, C., Li, A., Liu, X., Xing, Y., Shen, J., Huo, Z., Zhou, S., Liu, X., Xie, Y., et al. (2019) · Europe PMC (PubMed Central) · Cited by 42
Zhao, K., Wang, X., Xue, X., Li, L., & Hu, Y. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000666 · Cited by 44
Casafont, Í., Palanca, A., Lafarga, V., Berciano, M. T., & Lafarga, M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0869-0 · Cited by 46
Kim, Y. D., Li, T., Ahn, S.-W., Kim, D.-K., Lee, J.-M., Hwang, S.-L., Kim, Y.-H., Lee, C.-H., Lee, I.-K., Chiang, J. Y. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339887 · Cited by 42
Genetically engineered livestock for biomedical models
Rogers, C. S. (2016) · Transgenic Research · doi:10.1007/s11248-016-9928-6 · Cited by 42
Treatment of acute leukemia in children with ataxia telangiectasia (A-T)
Schoenaker, M. H. D., Suárez, F., Szczepański, T., Mahlaoui, N., & Loeffen, J. L. C. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.05.012 · Cited by 42
Metadata
- Authors
- Lavin, M. F.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Lavin, Martin F.
- ORCID
- Lavin, Martin F.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-10
- Volume
- 9
- Issue
- 10
- Pages
- 759-769
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2139777089
- Cited by
- 901
- References
- 126
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 17 · 2023: 19 · 2022: 36 · 2021: 43 · 2020: 36 · 2019: 42 · 2018: 26 · 2017: 54 · 2016: 50 · 2015: 45 · 2014: 63 · 2013: 76 · 2012: 90
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- ataxia telangiectasia, ATM protein, DNA damage response, genomic instability, cancer susceptibility, neurodegenerative diseases, signal transduction, cell cycle regulation
- MeSH terms
- Animals, Ataxia Telangiectasia, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Insulin Resistance, Models, Biological, Mutation, Neoplasms, Nerve Degeneration, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Genetic Predisposition to Disease, Metabolic Syndrome, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.